Not applicableUnknownNCT04029246What this trial is testingRe-engaging Patients With Hepatitis C Into CareWho this might be right forHepatitis C, Chronic Glasgow Royal Infirmary 1,000
Not applicableStudy completedNCT04384159What this trial is testingCombination Diagnostic Strategies in NAFLDWho this might be right forNon-Alcoholic Fatty Liver DiseaseChronic Liver Disease University Hospital, Montpellier 577
Post-approval studies (Phase 4)Looking for participantsNCT03855917What this trial is testingStrategic Treatment Reduction in Very Early Liver Disease With 4 Weeks Sofosbuvir Plus Glecepravir-pibrentasvirWho this might be right forHepatitis C Kirby Institute 30
Not applicableLooking for participantsNCT06180590What this trial is testingThe Efficacy of Vosevi in Treating DAA-experienced PatientsWho this might be right forChronic Hepatitis CMedication Reaction The Third Affiliated Hospital of Guangzhou Medical University 200
Post-approval studies (Phase 4)Study completedNCT03471624What this trial is testingTreatment Outcomes in Chronic Hepatitis B Patients on Sequential Therapy With Tenofovir Alafenamide (TAF)Who this might be right forHepatitis B, Chronic Stanford University 270
Not applicableStudy completedNCT04576897What this trial is testingVelacur by Sonic Incytes for Portal HypertensionWho this might be right forPortal HypertensionChronic Advanced Liver Disease Indiana University 70
Not applicableStudy completedNCT01201720What this trial is testingEffects on Plasma Exchange on Functional Capacity of Serum Albumin, Circulatory Dysfunction, Renal and Cerebral Function in Cirrhotic Patients With "Acute-on-chronic Liver Failure"Who this might be right forLiver CirrhosisLiver Failure Instituto Grifols, S.A. 12
Testing effectiveness (Phase 2)Study completedNCT04585789What this trial is testingAssess Intrahepatic and Peripheral Changes of Immunologic and Virologic Markers in Chronic Hepatitis B Virus InfectionWho this might be right forHepatitis B Janssen Research & Development, LLC 24
Large-scale testing (Phase 3)Ended earlyNCT01446250What this trial is testingAlisporivir (Deb025) and Boceprevir Triple Therapies in African American Participants Not Previously Treated for Chronic Hepatitis C Genotype 1Who this might be right forHepatitis C Debiopharm International SA 8
Post-approval studies (Phase 4)UnknownNCT02362490What this trial is testingEfficacy of Peginterferon Alpha 2a Therapy in Chronic Hepatitis B Patients Being Treated With Nucleoside(Acid) AnaloguesWho this might be right forChronic Hepatitis B Beijing Ditan Hospital 200
Testing effectiveness (Phase 2)Looking for participantsNCT07446491What this trial is testingEvaluate the Safety and Efficacy of PN20 in the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing an Elective ProcedureWho this might be right forThrombocytopenia Associated With Chronic Liver Disease Chongqing Peg-Bio Biopharm Co., Ltd. 54
Testing effectiveness (Phase 2)Study completedNCT02556372What this trial is testingLiver Test Study of Using JKB-122 in Autoimmune Hepatitis (AIH) Patients Who Are Refractory or Intolerant to Current TherapiesWho this might be right forAutoimmune Hepatitis TaiwanJ Pharmaceuticals Co., Ltd 20
Testing effectiveness (Phase 2)Study completedNCT05244057What this trial is testingHepalatide Combined With TAF and PEG-IFN as Finite Treatment of Chronic Hepatitis B PatientsWho this might be right forChronic Hepatitis B Shanghai HEP Pharmaceutical Co., Ltd. 8
Post-approval studies (Phase 4)Study completedNCT05355467What this trial is testingEfficacy and Safety of Ricovir® in Maintaining Durability of Viral Response in Chronic Hepatitis B Patients Who Have Been Treated With Viread® and Have Undetectable HBV DNA in SerumWho this might be right forChronic Hepatitis B Infection Mylan (Taiwan) Ltd 40
Large-scale testing (Phase 3)Not Yet RecruitingNCT06797011What this trial is testingEfficacy of Plasmapheresis in Patients of Drug-Induced Liver Injury (DILI) With Underlying Chronic Liver DiseaseWho this might be right forDrug Induced Liver InjuryChronic Liver Disease Institute of Liver and Biliary Sciences, India 96
Not applicableStudy completedNCT01508130What this trial is testingAn Observational Study of Peginterferon (e.g. Pegasys)-Based Direct Acting Antiviral Triple Therapy in Patients With Chronic Hepatitis C Genotype 1Who this might be right forHepatitis C, Chronic Hoffmann-La Roche 672
Early research (Phase 1)Looking for participantsNCT06680232What this trial is testingPhase 1 Study to Evaluate Safety and Antiviral Activity of PBGENE-HBV in Adult Patients With Chronic Hepatitis BWho this might be right forHEPATITIS B CHRONIC Precision BioSciences, Inc. 45
Not applicableUnknownNCT01464281What this trial is testingSwitch From Nucleotide to Peginterferon Alfa-2a in CHB Patients Achieving HBeAg Loss and HBV DNA <200IU/mlWho this might be right forChronic Hepatitis B The Second Affiliated Hospital of Chongqing Medical University 300
Not applicableStudy completedNCT00723892What this trial is testingAdherence in Patients Receiving PegIntron/Rebetol for Hepatitis C in Conjunction With a Psychotherapy Support Program (Study P04252)Who this might be right forHepatitis C, ChronicHepacivirus Merck Sharp & Dohme LLC 614
Not applicableActive Not RecruitingNCT05129904What this trial is testingPrecise Profiling of Liver Disease Patients With DPMAS Therapy, Treating Optimal Patients and Achieving Hard Endpoint (PADSTONE Study)Who this might be right forDPMAS Therapy in Liver Disease Patients Nanfang Hospital, Southern Medical University 1,300